Nonstandard abbreviations: ATF: activation transcription factor, BiP: binding immunoglobulin protein, CHOP: CCAAT/-enhancer-binding protein homologous protein, ER: endoplasmic reticulum, HFD: high-fat diet, IL: interleukin, MaR1: maresin 1, miRNA: microRNA, NAFLD: non-alcoholic fatty liver disease, PCLS: precision-cut liver slices, SPMs: specialized pro-resolving mediators, UPR: unfolded protein response.
INTRODUCTION
Endoplasmic reticulum (ER) is the intracellular organelle responsible for lipid biosynthesis, storage of Ca 2+ and the trafficking, maturation and folding of proteins (1) (2) (3) . Adverse and stressful conditions such as nutrient excess, elevated levels of free fatty acids (lipotoxicity), hypoxia and high or low glucose levels can pathologically alter ER homeostasis leading to the accumulation of unfolded or misfolded proteins, which is the most relevant feature of ER stress (4, 5) . Eukaryote cells have developed an evolutionary conserved cell response to mitigate ER stress and restore homeostasis, a process known as unfolded protein response (UPR) (6) (7) (8) . The UPR involves three transmembrane sensors/transducers: inositol-requiring kinase 1α (IRE1α), protein kinase R (PKR)-like ER kinase (PERK) and activating transcription factor 6 (ATF6), which culminate in the transcriptional regulation of a large subset of genes aimed at reestablishing ER homeostasis (7, 9) . These pathways are maintained in an inactive state through their association with the ER chaperone binding immunoglobulin protein (BiP or GRP78) the master regulator of UPR (10) . Failure of UPR to decrease ER stress leads to the activation of apoptotic pathways via ATF3 and CCAAT/-enhancer-binding protein homologous protein (CHOP), which operate downstream of ATF4 (11) . Failure of the ER adaptive capacity and UPR is also linked to the activation of inflammatory signaling pathways (12) .
ER stress is a hallmark of the metabolic syndrome including obesity and non-alcoholic fatty liver disease (NAFLD) (13) . NAFLD is a condition that encompasses a wide spectrum of hepatic disorders ranging from the simple accumulation of lipids in the cytoplasm of hepatocytes (steatosis) to the combination of steatosis with inflammation, a stage known as steatohepatitis or NASH (14) . NASH is the aggressive form of NAFLD and increases the risk for advanced liver disease culminating in hepatic fibrosis, cirrhosis and hepatocarcinoma (14) .
The mechanisms underlying the progression of NAFLD have not been completely delineated, but stressful conditions present in the liver of these patients, including an excess of free fatty acids such as palmitic acid (lipotoxicity) as well as low oxygen diffusion (hypoxia) have been proposed to induce ER stress in the liver (4, (15) (16) (17) (18) . This is important because unresolved ER stress leads to hepatocyte apoptosis, which is also a hallmark of NAFLD (2, 13) . Therefore, any intervention able to restore ER homeostasis prior to ER-stress-induced cell death may be useful for prevention and treatment of NAFLD.
A new family of endogenous bioactive lipid mediators has recently been identified to promote the return of the injured tissue to homeostasis (19) . This new genus of specialized proresolving mediators (SPMs) includes essential fatty acid-derived lipoxins, resolvins, protectins, and, more recently, maresins. Maresins are produced by macrophages from docosahexaenoic acid (DHA) and were first described by Serhan et al. (20) using lipidomics on self-resolving inflammatory exudates. The complete stereochemistry of maresin 1 (MaR1;
7R,14S-dihydroxydocosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid) and its biosynthesis from DHA via 12-lipoxygenase (12-LOX) were recently established (21) (22) (23) . MaR1 exerts organprotective actions, promotes enhanced tissue regeneration and possesses the characteristic pro-resolving actions (enhances macrophage phagocytosis and clearance of apoptotic PMN and microbial particles) of the other members of the SPM family (20) (21) (22) (23) (24) . In view of these properties and considering that MaR1 is a good template for developing potential resolutionbased therapies, in the current study we investigated whether MaR1 may protect liver cells from injury by preventing and/or resolving lipotoxic and hypoxia-induced ER stress under conditions commonly encountered in patients with NAFLD. OCT-embedded cryosections. Sections were visualized at x200 magnification in a Nikon Eclipse E600 microscope (Kawasaki, Japan).
MATERALS AND METHODS

Precision-cut liver slices (PCLS):
Twenty-week old C57BL/6J mice were anesthetized with ketamine/xylazine. The inferior vena cava was clipped, blood was allowed to drain for 1 min and the liver was excised and quickly placed into ice-cold DPBS for the last 6 h. In another set of experiments, PCLS were pre-treated with MaR1 (10 nM) before being exposed to lipotoxic damage induced by palmitate (0.5 mM) for 18 hours. A stock solution of palmitate (8 mM) conjugated to 18.4% free fatty acid (FFA)-bovine serum albumin (BSA) was prepared by gentle overnight agitation at 37ºC. The solutions were filtered and maintained at -20ºC for a maximum of 1 month. At the end of the incubation period, PCLS were snap-frozen in N 2 for further analysis.
Isolation of hepatocytes:
Hepatocytes were isolated from C57BL/6J mice by a three-step in situ perfusion procedure using 0.04% collagenase IV through the portal vein, as previously described (25) . The cell suspension was passed through a 100-μm cell strainer (Beckton °C and allowed to grow to confluence for 2 days, as described previously (25) . Confluent 3T3-L1 cells were cultured in adipocyte induction medium containing insulin (5 μg/mL), isobutylmethylxanthine (0.5 mM), dexamethasone (0.25 μM), penicillin/streptomycin (100 U/mL), and L-glutamine (4 mM) in DMEM supplemented with 10% FBS. After 2 days, the cells were cultured in continuation medium (5 μg/mL insulin) for 72 h and then maintained in DMEM supplemented with 10% FBS until exhibiting a mature adipocyte phenotype, as characterized by phase-contrast microscopy. At day 7-8 of differentiation, the cells were placed in 1% serum free/insulin free DMEM overnight before performing the experiments. Membranes were visualized as described above.
Gene expression analysis by real-time PCR:
Isolation of total RNA from liver and adipose tissue, hepatocytes and PCLS, was performed using the TRIzol reagent. RNA concentration was assessed in a NanoDrop-1000 spectrophotometer and its integrity tested in a Bioanalyzer 2100. cDNA synthesis from 0.5-1 µg of total RNA was performed using the High-Capacity cDNA Archive Kit (Applied Biosystems). Real-time PCR analysis for IL-10 
Analysis of 12/15-LOX by end-point reverse transcription-PCR:
End-point amplification of 12/15-LOX and glyceraldehyde-3 phosphate dehydrogenase (GAPDH) was performed with specific oligonucleotides as previously described (26) . PCR products were analyzed by electrophoresis in 2.0% agarose gels and visualized by Sybr safe staining, using a 100-bp DNA ladder (Invitrogen).
miRNA isolation: Total RNA containing miRNA was isolated from hepatocytes using RNeasy Micro Kit (Qiagen, Hilden, Germany) following manufacturer's instructions. Total RNA concentration was assessed in a NanoDrop-1000 spectrophotometer.
miRNA sequencing: Libraries for small RNA sequencing were prepared from 1 µg of total RNA using the TruSeq small RNA Sample Prep Kit (Illumina) according to the manufacturer's protocol. After adaptor ligation, reverse transcription, and PCR amplification, libraries were size-selected using 6% Novex® TBE Gels (ThermoFisher Scientific).
Fragments with insert sizes between 18 and 40 bp were cut from the gel, and DNA was Table S1 . A universal reverse primer is included in the miR-X miRNA FirstStrand Synthesis Kit. Statistical analysis: Statistical analysis of the results was performed by analysis of variance (one-way or two-way ANOVA) or unpaired Student's t-test. Results are expressed as mean ± SEM and differences were considered significant at P < 0.05.
RESULTS AND DISCUSSION
Livers from obese mice show increased ER stress. Role of free fatty acids.
Obese mice showed increased body, liver and WAT weight and higher serum insulin, glucose, triglycerides, cholesterol, AST and ALT levels than paired-aged lean mice ( Table S2) .
Analysis of H&E stained liver sections revealed signs of necroinflammation in obese mice (Fig. 1A) . These mice also showed extensive hepatic steatosis as indicated by the presence of significantly increased area stained with Oil Red-O (Fig. 1A) . Consistent with the view that an excessive influx of free fatty acids leading to steatosis is a potent inducer of ER stress and cell injury in obesity-induced NAFLD (13, 29, 30) , livers from obese mice displayed a remarkable induction of eif2α and JNK phosphorylation and up-regulation of downstream targets ATF3 and BiP (Fig. 1B) . No changes were observed in IRE1α phosphorylation and CHOP expression (Fig. 1B) . ATG7, a marker of autophagy, was slightly increased in obese livers (Fig. 1B) . To provide further evidence linking hepatic steatosis to ER stress, we next modeled hepatic lipotoxicity in vitro by incubating primary hepatocytes with palmitic acid.
The levels of this saturated fatty acid, as estimated by the ratio between palmitoleic and palmitic acids (C16:1/C16:0) (28), were remarkably increased in livers from obese mice (Fig.   1C) . A schematic diagram of the design of the experiments using palmitate at pathophysiological concentrations (i.e. 0.5 mM) (18, 30) is shown in Fig. 1D . As shown in 
MaR1 ameliorates lipotoxic ER stress in primary mouse hepatocytes.
MaR1 is a biologically active lipid mediator that belongs to the pro-resolving SPM family (20) . In humans, MaR1 is generated from DHA through the activity of the 12-LOX enzyme, which mouse homolog is 12/15-LOX (21-23). In mouse liver, constitutive expression of 12/15-LOX was detected (Fig 2A) , which was not altered under obese conditions (Fig 2B) .
MaR1 exerts potent cytoprotective actions and promotes tissue homeostasis in several disease models (20) (21) (22) (23) (24) . To investigate whether MaR1 also exerts protective actions against obesityinduced hepatic ER stress, we incubated hepatocytes with nanomolar concentrations of MaR1 before initiating the palmitate lipotoxic model. As shown in Fig. S1 , in the absence of the lipotoxic stimulus (i.e. palmitate), MaR1 did not induce any change on markers of ER stress in resting hepatocytes. In contrast, increased peif2α/eif2α ratio and spliced XBP1 (XBP1s), a transcription factor generated through the action of IRE1 endoribonuclease domain (31), was seen in hepatocytes treated for 18 h with palmitate (Fig. 2C) . Moreover, lipotoxicity induced ATG7 and LC3-II protein levels, while repressing p62 (Fig. 2C) . Importantly, MaR1
pre-treatment resulted in a return of hepatocytes to homeostasis by reducing ER stress markers such as peif2α and XBP1s and the protein levels of the autophagic markers p62, ATG7 and LC3-II (Fig. 2C) . These changes in p62 and LC3-II are consistent with those previously described by Borgeson et al. (32) in adipose tissue from HFD-induced obese mice in response to the SPM LXA 4 and its stable analog benzol-LXA 4 . In addition, MaR1 returned the palmitate-induced expression of ATF3, CHOP, BiP and Erdj4 to normal (Fig. 2D) . MaR1 did not modulate EDEM1 and ATF4 in response to palmitate (Fig. S2A) . Down-regulation of the ER stress markers ATF3, BiP and Erdj4 was also seen when MaR1 was applied therapeutically during the last 6 hours of palmitate lipotoxic damage (Fig 2E) , although the response was not as intense as when the cells were pre-treated with MaR1.
MaR1 protects hepatocytes from lipoapoptosis.
We Consistent with this view, we detected a substantial reduction in the number of TUNELpositive apoptotic hepatocytes when MaR1 was added to the cell culture medium (Fig. 3B) .
Of interest, the cytoprotective actions of MaR1 were accompanied by a reduction in the number of intracellular lipid vacuoles, as seen in hepatocytes stained with Oil Red-O (Fig.   S2B ). Together, these findings add new value to previous observations with RvD1, another SPM generated from DHA, which displays protective actions against obesity-induced hepatic steatosis and inflammation (33, 34) .
MaR1 ameliorates lipotoxic ER stress in PCLS and promotes phagocytosis in Kupffer cells.
PCLS are a very useful and reliable tool to study the global response of liver cells to injury because this model preserves cell-cell interactions in the original three-dimensional hepatic architecture (35) . In these experiments, PCLS were exposed to palmitate for 18 h in the presence or absence of MaR1. A schematic diagram of the experimental design is shown in Figure 4A . As expected, palmitate induced UPR in PCLS by up-regulating ATF4, BiP, EDEM1 and Erdj4 ( Figure 4B ). Of note, MaR1 significantly reduced ATF3 and ATF4
expression, while up-regulating the pro-survival chaperone BiP. This is of importance because BiP is a master regulator of the UPR due to its role as a major ER chaperone with anti-apoptotic properties as well as its ability to control the activation of transmembrane ER stress sensors (IRE1, PERK and ATF6) (36) . On the other hand, palmitate was not a strong inducer of inflammation in this organotypic model and only induced a modest increase in IL-β expression (Fig. S2C) . Nevertheless, under these circumstances, MaR1 significantly reduced TNFα, NLRP3 and IL-β expression in palmitate-challenged PCLS (Fig. S2C) . We also explored the actions of MaR1 on individual liver cells, namely hepatocytes, which are the predominant liver cell type in PCLS, and Kupffer cells, which are the primary liver resident macrophages engaged in inflammatory responses (37) . As expected no major changes in inflammatory markers were observed in hepatocytes (data not shown), whereas Kupffer cells responded to MaR1 with an enhanced phagocytic activity, which is a cardinal sign of active resolution of inflammation ( Fig. 4C) (38, 39) . Indeed, MaR1 induced a concentrationdependent increase in Kupffer cell phagocytosis with a maximal response at 10 nM, diminishing at higher concentrations (Fig. 4C) , in a bell-shaped like curve characteristic for SPMs as well as for other lipid mediators (40, 41) . This observation indicates that MaR1
potentiates the phagocytic function of resident liver macrophages, which are responsible for engulfing (phagocyte) and removing cell debris and pathogens under homeostatic conditions Interestingly, MaR1 was able to enhance phagocytosis in a concentration-dependent manner in Kupffer cells even after these cells were challenged with palmitate (Fig. 4D) . In this case, the concentration-response curve was shifted to the right, suggesting that higher doses of down-regulated) were identified after palmitate challenge (Fig. 5B) . These miRNAs are listed in Table S3 . Pre-treatment of palmitate-challenged hepatocytes with MaR1 yielded a specific signature of 44 miRNAs, of which 24 were up-regulated and 20 down-regulated (Fig. 5B) .
The fold changes of these 44 miRNAs are given in Fig. 5C and Table S4 . Validation of a subset of the miRNA found to be differentially regulated by MaR1 in the RNAseq analysis was performed by real-time PCR (Fig. 5D and Fig. S3 ). Moreover, confirmation that MaR1 not only modulated the levels of these miRNAs but also the expression of their targets (i.e.
BCL2, XBP1 and ATG12) is shown in Fig. 5D . In particular, among the miRNA up-regulated by MaR1 (Pal+MaR1), we identified miRNA such as miR181a-1-3p and miR-129-2-3p that target ATG12 and BCL2 family members involved in ER stress and apoptosis (44) . Another example is miR-125b which was up-regulated by MaR1 and has been described to Livers from obese mice show remarkable hypoxia. Association with ER stress.
In addition to lipotoxicity, hypoxia is recognized as an initiator of ER stress (44) and has been implicated as a causative factor in the progression of NAFLD. Indeed, hypoxic conditions have been reported in the liver of HFD-induced obese mice and intermittent hypoxia has been associated with a predisposition to liver injury (17, 45) . In this regard, livers from obese mice showed increased hypoxia inducible factor-1 (HIF-1) expression at both mRNA ( Fig. S4A) and protein (Fig. S4B ) levels. The observation that up-regulation of HIF-1 was more evident at protein level is consistent with the fact that HIF-1α is mainly regulated at the posttranscriptional level (46) . Since HIF-1α is difficult to monitor in vitro due to its short half-life upon re-oxygenation (47) , in this study we measured carbonic anhydrase 9 (CA9), which is a useful surrogate marker of the transcriptional activity of HIF-1α under hypoxic conditions (48, 49) . As shown in Fig. 6A and Fig 6B, livers from obese mice and hepatocytes cultured under hypoxic conditions (1% O 2 ) showed significantly increased CA9 expression. Moreover, hypoxic hepatocytes showed a time-response induction in GLUT-1 (Fig. 6C) , which is another surrogate marker of HIF-1α activity (50) . No changes in HIF-1 mRNA expression were detected in cultures of hypoxic hepatocytes (Fig. S4C) . Of interest, hypoxia was associated with increased phosphorylation of the ER stress markers eif2α, IRE1α and JNK in primary hepatocytes (Fig. 6D) . The expression of the downstream effectors ATF3 and CHOP, which play a central role in mediating apoptotic cell death (18) , were also increased in hypoxic hepatocytes (Fig. 6E) . In contrast, the ATF6 pro-survival target chaperone BiP was reduced by hypoxia (Fig. 6E) . Consistent with previous studies (51), hypoxia stimulated the autophagic markers LC3-II and ATG7 in primary hepatocytes, while reducing p62 in a timedependent manner (Fig. 6F) .
MaR1 ameliorates hypoxia-induced ER stress and promotes cell survival in primary hepatocytes.
As shown in Fig. 7A , MaR1 markedly down-regulated hypoxia-induced peif2α and pIRE1α to a similar extent to that of the chemical chaperone 4-phenylbutyrate (4-PBA). Notably, MaR1
actions on peif2α and pIRE1α in hypoxic hepatocytes were concentration-dependent (Fig.   7B) . pJNK, which is activated by the cytosolic IRE1 kinase domain (31) , was also attenuated by MaR1 in a concentration-dependent manner (Fig. 7B) . XBP1s was also downregulated by MaR1 (Fig. 7B) . Importantly, attenuation of hypoxia-induced ER stress by
MaR1 translated into reduced expression of ATF3 and its putative target and pro-apoptotic gene CHOP, without changes in the chaperone BiP or its cochaperone Erdj4 (Fig. 7C) .
Furthermore, MaR1 reduced ATG7 in primary hepatocytes exposed to hypoxia (Fig. 7D) . Of interest, MaR1 protected hepatocytes from apoptotic cell death induced by TNFα + actinomycin, as revealed by a significant reduction in caspase 3/7 activity in cells incubated with this SPM (Fig. 7E) . As expected, the chemical chaperone 4-PBA completely blunted caspase 3/7 activity in hepatocytes undergoing the same treatment (Fig. 7E) .
Effects of MaR1 on PCLS upon hypoxic conditions.
Hypoxia is described as a potent trigger of hepatic inflammation (33) , which together with lipotoxicity and cell injury are key features of progressive obesity-induced NASH (13, 14, 52) . Consistent with previous studies (25, 33) , obese mice showed increased serum markers of liver injury (Table S2 ) and up-regulated expression of inflammatory genes such as IL-1β, CCR7 and PAI-1 (Fig. S5A) in the liver. Markers of inflammation were also triggered by hypoxia in primary hepatocytes, although MaR1 was ineffective in modulating this response, except for a very modest increase in IL-10 expression (Fig. S5B) . A more pronounced inflammatory response was observed in PCLS exposed to hypoxia, in which condition, MaR1 significantly down-regulated IL-1β and TNF (Fig. S5C) . MaR1 also significantly inhibited the expression of the NLRP3 inflammasome in PCLS challenged with hypoxia (Fig. S5D) .
This is of particular interest because NLRP3 inflammasome, IL-1β and TNF are key factors involved in immunity and inflammation linked to the ER-induced UPR (36) .
MaR1 induces a specific miRNA signature in hepatocytes exposed to hypoxia.
Similar to hepatocytes exposed to palmitate lipotoxicity, we also profiled the miRNA signatures associated with MaR1 actions in primary hepatocytes challenged by hypoxia.
Under hypoxic conditions, 102 miRNAs (36 up-regulated and 66 down-regulated) were differentially expressed (Fig. S6A, Fig. S6B and Table S5 ), whereas MaR1 differentially regulated 32 miRNAs (17 up-regulated and 15 down-regulated) in hypoxic hepatocytes ( Fig.   S6C and Fig. 6D ). Under MaR1 treatment, the top ranked enriched pathways identified by the DAVID bioinformatics tool were the GO terms metabolic process, phosphorylation and protein modification process (Fig. S6E) .
MaR1 ameliorates lipotoxic ER stress in adipocytes.
Finally, we investigated whether the inhibitory actions of MaR1 on ER stress were restricted to the liver or were common to other insulin-sensitive tissues, such as the WAT. This is of relevance in the context of NASH because impaired WAT function in obesity exerts a direct impact on the liver (53) . WAT from obese mice showed adipocyte hypertrophy accompanied by an induction of eif2α and JNK phosphorylation and an up-regulation of ATF3 ( Fig. S7A and Fig. S7B ). IRE1phosphorylation was significantly decreased in obese adipose tissue, a finding previously described in conditions of persistent ER stress (54) . To investigate whether WAT is also sensitive to the MaR1 actions on ER stress, we performed experiments in differentiated 3T3 adipocytes incubated with palmitate as a model of lipotoxic damage (55) .
As shown in Fig. S7C , MaR1 down-regulated Erdj4, ATF3, CHOP, EDEM1 and ATF4 in differentiated adipocytes exposed to lipotoxic ER stress. These findings confirm that the protective actions of MaR1 are not restricted to the liver.
In a previous study carried out in our laboratory, we had assessed the ability of another member of the SPM family, RvD1, to accelerate the resolution process during calorie restriction in a HFD-induced obesity model (33) . In that study, we observed a remarkable improvement in the hepatic inflammatory component in mice receiving RvD1, in a large part related to the polarization of hepatic macrophages towards a pro-resolutive M2 phenotype (33) . In the current study, we reinforced this concept by demonstrating that the SPM MaR1 promotes efferocytosis in Kupffer cells, the liver resident macrophages. Moreover, in the current study we added more value to the protective actions of SPMs on obesity-induced NAFLD by demonstrating that MaR1 was able to prevent ER stress and to properly manage the UPR response. ER stress is an early event in the inflammatory process, and therefore our current findings confirm that SPM not only promote resolution but also block early triggers of inflammation. Moreover, in our study with RvD1 we observed that this SPM was able to counteract hypoxia-induced inflammation in the PCLS model, meanwhile in the current study we observed that MaR1 counteracts both hypoxia-and lipotoxic-induced ER stress in PCLS.
Interestingly, in both studies, SPM actions were related to a specific miRNA signature, suggesting that pro-resolving mediators exert their pleiotropic actions by regulating the transcription of a large set of genes.
In summary, the results of the current investigation identify the lipid mediator MaR1 as a potent modulator of the ER stress-triggered UPR. The highly-conserved UPR signaling pathway allows cells to adapt and respond to ER stressors, but if this response becomes chronic or it is too intense, as is the case of liver cells under NAFLD conditions, fail to adapt and the UPR activates inflammation and pro-apoptotic pathways leading to cell death (9).
Therefore, our findings demonstrating that MaR1 is able to promote the resolution of lipotoxic and hypoxia-induced ER stress in hepatocytes are very relevant for the pathogenesis of NAFLD and the prevention of this metabolic syndrome-associated hepatic complication.
There are some aspects of our study that deserve consideration. Firstly, we used physiological stimuli such as free fatty acids (lipotoxicity) to disturb protein folding and to activate UPR in liver cells, instead of pharmacological agents such as thapsigargin and tunicamycin, which triggers strong and typically unrecoverable ER stress (56) (57) (58) . Secondly, we used very low concentrations of MaR1 (at the nanomolar range) to reduce ER stress in hepatocytes, levels that can be easily achieved endogenously during the intake of omega-3 fatty acids in the diet. 
